These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 2164551)
1. [Targeting anticancer chemotherapy dispersed in lipid contrast medium in hepatoblastoma in childhood]. Ohnuma N; Takahashi H; Tanabe M; Yoshida H; Iwakawa M; Kuriyama Y Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):788-92. PubMed ID: 2164551 [TBL] [Abstract][Full Text] [Related]
2. [Targeting chemotherapy of hepatocellular carcinoma by arterial administration of anticancer agents dissolved in lipiodol]. Konno T Gan To Kagaku Ryoho; 1987 Feb; 14(2):373-80. PubMed ID: 3028275 [TBL] [Abstract][Full Text] [Related]
3. [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma]. Konno T; Maeda H Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1043-50. PubMed ID: 2839112 [TBL] [Abstract][Full Text] [Related]
4. Intraarterial chemotherapy with lipid contrast medium for hepatic malignancies in infants. Ogita S; Tokiwa K; Taniguchi H; Takahashi T Cancer; 1987 Dec; 60(12):2886-90. PubMed ID: 2824018 [TBL] [Abstract][Full Text] [Related]
5. [Targeted chemotherapy of hepatocellular carcinoma using Lipiodol as a carrier]. Konno T; Oda T; Nagamitsu A; Tabaru K; Yamashita R; Kai Y Gan To Kagaku Ryoho; 1996 Sep; 23(11):1392-9. PubMed ID: 8854762 [TBL] [Abstract][Full Text] [Related]
6. Lipiodol drug targeting in the treatment of primary hepatocellular carcinoma. Kanematsu T; Matsumata T; Furuta T; Shirabe K; Yamagata M; Utsunomiya T; Sugimachi K Hepatogastroenterology; 1990 Oct; 37(5):442-4. PubMed ID: 2174820 [TBL] [Abstract][Full Text] [Related]
7. [Systemic chemotherapy of hepatocellular carcinoma]. Okazaki N; Yoshino M; Yoshida T; Hizikata A; Hasegawa H Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1584-8. PubMed ID: 3015033 [TBL] [Abstract][Full Text] [Related]
8. [Arterial administration of oily anticancer agents dissolved in lipiodol fluid in recurrence of hepatoma after hepatic resection and in metastatic liver cancer]. Ohtsuka N; Konno T Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1351-8. PubMed ID: 2837992 [TBL] [Abstract][Full Text] [Related]
9. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection. Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671 [TBL] [Abstract][Full Text] [Related]
10. [Eight cases of non-resectable hepatocellular carcinoma surviving for more than 3 years after Lipiodol administration]. Shirabe K; Kanematsu T; Utsunomiya T; Furuta T; Yamagata M; Matsumata T; Sugimachi K; Yasumori K; Masuda K Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2974-7. PubMed ID: 2551238 [TBL] [Abstract][Full Text] [Related]
11. [Arterial infusion of anticancer agent and lipiodol using a totally implanted drug delivery system]. Kishimoto W; Nonami T; Nakao A; Harada A; Kuroe K; Haba T; Takagi H Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2531-4. PubMed ID: 2843118 [TBL] [Abstract][Full Text] [Related]
12. [A case of recurrent hepatocellular carcinoma after hepatic resection surviving over five years by hepatic arterial infusion of lipiodol-anticancer drug suspension]. Takeda M; Mizuguchi N; Ohyama Y; Suzuki S; Itoh M; Mukojima T; Kumagai T; Iwasaki H Gan To Kagaku Ryoho; 1991 Jul; 18(8):1367-70. PubMed ID: 1648891 [TBL] [Abstract][Full Text] [Related]
13. [Hepatic arterial infusion chemotherapy of hepatocellular carcinoma]. Ishibashi T; Okajima K; Isozaki H; Morita S; Nakata E; Nishimura J; Iga C; Amioka K; Tanimura M; Hara H Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2778-81. PubMed ID: 2551222 [TBL] [Abstract][Full Text] [Related]
14. Preoperative transcatheter selective arterial chemoembolization in treatment of unresectable hepatoblastoma in infants and children. Li JP; Chu JP; Yang JY; Chen W; Wang Y; Huang YH Cardiovasc Intervent Radiol; 2008; 31(6):1117-23. PubMed ID: 18560935 [TBL] [Abstract][Full Text] [Related]
15. [Anticancer effect and side effect of arterial chemoembolization using cis-diamine-dichloroplatinum (II)/4-0-tetrahydropyranyl-adriamycin-lipiodol (CTL) suspension on hepatocellular carcinoma]. Takeshita T; Inoue H; Miyazono N; Hori A; Harada O; Satake M; Kanetsuki I; Nishida H; Sagara K; Shinmaki H Gan To Kagaku Ryoho; 1992 Sep; 19(11):1867-72. PubMed ID: 1381572 [TBL] [Abstract][Full Text] [Related]
16. Intraarterial injection of anti-tumor drugs dispersed in lipid contrast medium: a choice for initially unresectable hepatoblastoma in infants. Ogita S; Tokiwa K; Taniguchi H; Takahashi T J Pediatr Surg; 1987 May; 22(5):412-4. PubMed ID: 3035159 [TBL] [Abstract][Full Text] [Related]
17. [Studies on the effectiveness of adjuvant hepatic arterial chemotherapy after hepatectomy for primary or metastatic liver cancer]. Isshiki K; Nonami T; Kishimoto W; Katoh H; Akaza K; Harada A; Nakao A; Takagi H Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1634-7. PubMed ID: 2167638 [TBL] [Abstract][Full Text] [Related]
18. [Transarterial "pile-up" infusion therapy of cisplatin and lipiodol emulsion in hepatic malignancies without TAE (transcatheter arterial embolization)]. Onohara S; Ogita M; Shimada J; Hiraki Y; Abeyama K; Nakajo M Gan To Kagaku Ryoho; 1992 Mar; 19(3):315-21. PubMed ID: 1311912 [TBL] [Abstract][Full Text] [Related]
19. [Clinical study of intrahepatic arterial infusion of unresectable hepatoblastoma and hepatocarcinoma in children]. Hamada H; Sasaki F; Hata Y; Sawada H; Tamura M; Abe T; Sato N; Une Y; Uchino J; Saito H Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2783-7. PubMed ID: 2476963 [TBL] [Abstract][Full Text] [Related]
20. Optimal strategy of preoperative transcatheter arterial chemoembolization for hepatoblastoma. Ohtsuka Y; Matsunaga T; Yoshida H; Kouchi K; Okada T; Ohnuma N Surg Today; 2004; 34(2):127-33. PubMed ID: 14745612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]